by Sowmya Viswanathan | Jun 19, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Stacey Johnson | Apr 13, 2018
For those who aren’t familiar with THIW, there are parties but no films getting their world premieres. The comparison I’m making in the title is to the fact THIW is becoming a must-attend week-long event, with so much going on from morning to night, that serious...
by Sowmya Viswanathan | Mar 12, 2018
Dr. Sheng Lin-Gibson is the Chief of Biosystems and Biomaterials Division at the U.S. National Institute of Standards and Technology (NIST) and directs its Regenerative Medicine Programs. She serves as the Convenor of ISO/TC 276: Biotechnology Working Group...
by Sowmya Viswanathan | Jan 8, 2018
In this month’s blog on addressing specific bioprocess and bioanalytical challenges to develop Cell and Gene Therapies (CGTs), we hear from Dr. Nick Timmins on quantifying performance of CGTs using cell yield, and some of the methods to measure it, as a metric...
by Sowmya Viswanathan | Nov 30, 2017
The recent FDA approvals of Kymriah™ for the treatment of children and young adults with B-cell Acute Lymphoblastic Leukemia, and Yescarta™ to treat adults with certain types of non-Hodgkin lymphoma, and the unanimous endorsement by an FDA advisory committee of a gene...
Comments